Postponement of the Combined General Meeting at Quantum Genomics

Quantum Genomics has decided to postpone its Combined General Meeting, originally scheduled for June 30, 2025. This postponement is part of a strategic repositioning and financial restructuring of the company. The Board of Directors emphasizes that these steps are essential to ensure the continuity of the company's business.

A request has been filed with the President of the Paris Economic Activities Court. This request seeks to extend until October 31, 2025, the legal deadline for holding the meeting to approve the accounts for the financial year ending December 31, 2024.

Shareholders will be informed of the new date by press release. The notice of meeting will be published in the Bulletin des Annonces Légales et Obligatoires and in a legal announcements newspaper.